Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gu, D.
Right arrow Articles by Sarvetnick, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gu, D.
Right arrow Articles by Sarvetnick, N.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 44, Issue 10 1161-1164, Copyright © 1995 by American Diabetes Association


ARTICLES

Treatment of IFN-gamma transgenic mice with anti-IFN-gamma reveals the remodeling capacity of the adult pancreas

D Gu, L Molony, T Krahl and N Sarvetnick
Department of Neuropharmacology, Scripps Research Institute, La Jolla, CA 92037, USA.

Pancreatic expression of gamma-interferon (IFN-gamma) initiates a cascade of pathogenic changes that include pancreatic inflammation, islet cell destruction, hyperglycemia, and islet regeneration. In this study, we explore the developmental plasticity of the adult pancreas and particularly its ability to return to normoglycemia and to remodel itself from an advanced pathogenic state. This was approached by treating adult transgenic mice with a pulse of anti-IFN-gamma antibody and determining the functional and morphological status of the pancreas. We demonstrated that anti-IFN-gamma antibody administration led to the reduction of hyperglycemic blood glucose levels in transgenic mice. We also observed that the pancreas returned from a profoundly perturbed state toward normality. Analysis of the mitotic index indicated that cell proliferation previously associated with islet cell regeneration was greatly reduced after anti-IFN-gamma administration. Our results highlight the ability of the adult pancreas to remodel itself and return from a complex pathological state to normalcy once the trophic signal inducing this pathology is removed. These data also suggest that anti-IFN-gamma administration may have important clinical implications for treatment of chronic pancreatitis in humans.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
Y. Chen, M. M.W. Chong, R. Darwiche, H. E. Thomas, and T. W.H. Kay
Severe Pancreatitis with Exocrine Destruction and Increased Islet Neogenesis in Mice with Suppressor of Cytokine Signaling-1 Deficiency
Am. J. Pathol., September 1, 2004; 165(3): 913 - 921.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. Christen, T. Wolfe, U. Mohrle, A. C. Hughes, E. Rodrigo, E. A. Green, R. A. Flavell, and M. G. von Herrath
A Dual Role for TNF-{{alpha}} in Type 1 Diabetes: Islet-Specific Expression Abrogates the Ongoing Autoimmune Process When Induced Late but Not Early During Pathogenesis
J. Immunol., June 15, 2001; 166(12): 7023 - 7032.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Wang, A. Bhattacharjee, Z. Zuo, F. Hu, R. E. Honkanen, P.-O. Berggren, and M. Li
A Low Voltage-Activated Ca2+ Current Mediates Cytokine-Induced Pancreatic {beta}-Cell Death
Endocrinology, March 1, 1999; 140(3): 1200 - 1204.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1995 by the American Diabetes Association.